The role of Septin6 Group in Murine and Human Hematopoiesis
The role of Septin6 Group in Murine and Human Hematopoiesis
批准号:
10718515
负责人:
DAVID A WILLIAMS
金额:
$35.4万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2026-05-31
关键词:
AdoptedAffectAgingAmino Acid Sequence HomologyAmino Acid SubstitutionAmino AcidsApoptosisAwarenessBloodBundlingC-terminalCD34 geneCSF3 geneCell CycleCell Differentiation processCell NucleusCell ProliferationCell divisionCell physiologyCellsClinicalCodon NucleotidesComplexCytokinesisDataDiffusionEngraftmentExocytosisExonsFilamentGTP Binding DomainGenesGerm-Line MutationGrowthGuanosine Triphosphate PhosphohydrolasesHematopoiesisHematopoieticHematopoietic stem cellsHomingHumanIn VitroIndividualLinkMammalian CellMarrowMicrofilamentsModelingMusMutationMyelogenousMyeloid CellsN-terminalNatureNeutropeniaNewborn InfantNucleotidesPathologicPathway interactionsPatientsPhenocopyPhenotypePlayProliferatingProlineProteinsPublicationsRefractoryRegulationReportingRoleStructureSyndromeTetraploidyVariantVesicleXenograft Modelcell motilitycombinatorialin silicoknock-downmalemembermutantnegative affectnovelpredictive modelingprogenitortrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(PLEASE KEEP IN WORD, DO NOT PDF)
Title: The role of Septin6 Group in Murine and Human Hematopoiesis
1 R01 DK137172-01
Septins are highly conserved GTPase proteins which regulate a variety of cellular functions including cytokinesis, polarity, cell cycle, vesicle trafficking, exocytosis, and creation of diffusion barriers. We have recently identified a non-syndromic newborn with severe neutropenia (Renella, AJH 2022) with a novel X-linked germline mutation in the C-terminus of SEPTIN6 gene (SEPTIN6 c.1282T>C p.428Glnext*9) associated with dysmyelopoiesis. Editing the germline mutation into normal male CD34+ hematopoietic stem and progenitor cells (HSC/P) phenocopied key pathologic features of the clinical syndrome, including large, multinucleated nuclei and reduced myeloid progenitor growth in vitro (preliminary data). The C-terminus has been proposed to play a key role in filament stabilization, bundling and bending as well as interactions with other septins and in silico modeling suggest the addition of 9 amino acids (aa) associated with the SEPTIN6 c.1282T>C p.428Glnext*9 mutation would alter function by interfering with SEPTIN6 protein interactions. Based on our initial publication, a second patient with severe neutropenia has since been identified in Seattle with a distinct mutation in the same codon (SEPTIN6 c.1282T>A) (Mohamad, Allensbach, Williams, accepted for presentation, ASH 2022). While the aa substitution is different, modeling predicts that SEPTIN6 variants adopt the same structure. Both identified patients had a high degree of myeloid tetraploidy in the marrow and were refractory to G-CSF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
-
批准号:10083551
-
项目类别:
-
资助金额:$120.04万
-
财政年份:2020
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
-
批准号:10179447
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2017
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
-
批准号:9363943
-
项目类别:
-
资助金额:$167.34万
-
财政年份:2017
-
负责人:DAVID A WILLIAMS
-
依托单位:
ConProject-005
-
批准号:10594167
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
ConProject-006
-
批准号:10609202
-
项目类别:
-
资助金额:$10.19万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene Therapy for SCID-X1 with Low Dose Busulfan and a SIN-lentiviral Vector
-
批准号:10827632
-
项目类别:
-
资助金额:$128.56万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
ConProject-003
-
批准号:10594165
-
项目类别:
-
资助金额:$9.2万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
Development of novel selective Rac inhibitors for refractory leukemias
-
批准号:9176356
-
项目类别:
-
资助金额:$63.82万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
-
批准号:10207386
-
项目类别:
-
资助金额:$77.85万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
ConProject-004
-
批准号:10594166
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
Development of novel selective Rac inhibitors for refractory leukemias
-
批准号:9319224
-
项目类别:
-
资助金额:$60.3万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
ConProject-002
-
批准号:10594164
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
ConProject-001
-
批准号:10594163
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
-
批准号:9977108
-
项目类别:
-
资助金额:$98.23万
-
财政年份:2016
-
负责人:DAVID A WILLIAMS
-
依托单位:
Translational and clinical studies targeting y-globin modulation
-
批准号:8866459
-
项目类别:
-
资助金额:$146.12万
-
财政年份:2013
-
负责人:DAVID A WILLIAMS
-
依托单位:
Translational and clinical studies targeting y-globin modulation
-
批准号:8467857
-
项目类别:
-
资助金额:$150.19万
-
财政年份:2013
-
负责人:DAVID A WILLIAMS
-
依托单位:
Translational and clinical studies targeting y-globin modulation
-
批准号:8722609
-
项目类别:
-
资助金额:$145.38万
-
财政年份:2013
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
-
批准号:8523765
-
项目类别:
-
资助金额:$57.16万
-
财政年份:2010
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
-
批准号:8719920
-
项目类别:
-
资助金额:$60.81万
-
财政年份:2010
-
负责人:DAVID A WILLIAMS
-
依托单位:
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
-
批准号:8318573
-
项目类别:
-
资助金额:$97.76万
-
财政年份:2010
-
负责人:DAVID A WILLIAMS
-
依托单位:
海外基金